In light of this, we hypothesise that reduced BMP9/10 production leading to reduced endothelial function, when combined with the additional impact of sEng on other factors, such as TGFβ, at the hepatic or pulmonary level, may promote HPS or PoPH. Here, TGFB1 is linked to Pulmonary arterial hypertension associated with portal hypertension.